In the MC38 murine colon carcinoma model, three studies investigated the use of a peptide vaccine, targeting a previously identified neoepitope in the Adpgk protein [14], delivered via synthetic nanoparticles [31, 32] or albumin/albumin-binding vaccine (AlbiVax) complexes [28]. The gene discussed is ALB; the disease is colon carcinoma.